Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

5.8K
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
5.8K
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

555
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
555
Controls in Experiments01:13

Controls in Experiments

14.7K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.7K
Bias01:22

Bias

7.2K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
7.2K
Censoring Survival Data01:09

Censoring Survival Data

511
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asymptotic validity of Schoenfeld's sample size formula for the Cox proportional hazards model via the Wald test approach.

Statistical methods in medical research·2026
Same author

A Note on the Sample Size Formula for a Win Ratio Endpoint.

Statistics in medicine·2025
Same author

Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.

BMC medical research methodology·2024
Same author

A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials.

Trials·2023
Same author

Factors Affecting the Outcome of Medical Treatment in Cats with Obstructive Ureteral Stones Treated with Tamsulosin: 70 Cases (2018-2022).

Veterinary sciences·2022
Same author

Optimization of dose selection using multiple surrogates of toxicity as a continuous variable in phase I cancer trial.

Contemporary clinical trials·2021

Related Experiment Video

Updated: Jan 11, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Power priors and type I error control: constrained borrowing of external control data.

Se Yoon Lee1

  • 1Department of Statistics, Texas A&M University, College Station, Texas, USA.

Journal of Biopharmaceutical Statistics
|November 13, 2025
PubMed
Summary

This study introduces a new power prior method for hybrid clinical trial designs. It effectively uses external control data to boost statistical power while preventing bias and maintaining type I error rates.

Keywords:
Effective sample sizePower prior methodborrowing external controlhybrid designstype I error control

More Related Videos

Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

9.1K
Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

4.4K

Related Experiment Videos

Last Updated: Jan 11, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

9.1K
Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

4.4K

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Hybrid trial designs combine randomized controlled trial (RCT) data with external controls to enhance statistical power and efficiency.
  • The power prior methodology offers a framework for analyzing hybrid designs, but external data can introduce bias, especially with prior-data conflict.
  • Bias in external control data can lead to incorrect treatment effect estimates, potentially resulting in flawed regulatory decisions.

Purpose of the Study:

  • To develop a novel power prior method for incorporating historical control data in hybrid designs.
  • To safeguard against type I error rate inflation beyond acceptable nominal levels when using external data.
  • To provide a scientifically rigorous strategy for leveraging external control data in clinical trial design.

Main Methods:

  • Development of a new power prior methodology tailored for hybrid designs.
  • Incorporation of mechanisms to control the type I error rate when borrowing external control data.
  • Validation through comprehensive simulation studies and an illustrative case example.

Main Results:

  • The proposed method effectively incorporates historical control data into hybrid designs.
  • The approach successfully safeguards the type I error rate, preventing inflation beyond predefined levels.
  • Simulation studies and the example demonstrated the practical advantages and reliability of the method.

Conclusions:

  • The novel power prior method offers a robust solution for utilizing external control data in hybrid trials.
  • This approach enhances trial efficiency and statistical power while mitigating risks associated with data conflict and bias.
  • The method provides trial sponsors with a reliable strategy for constructing efficient and valid hybrid clinical trial designs.